Editorial Comment on: Tolterodine Treatment Improves Storage Symptoms Suggestive of Overactive Bladder in Men Treated With α-Blockers
Gespeichert in:
| Veröffentlicht in: | European urology 2009-09, Vol.56 (3), p.542-543 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 543 |
|---|---|
| container_issue | 3 |
| container_start_page | 542 |
| container_title | European urology |
| container_volume | 56 |
| creator | Speakman, Mark J |
| description | |
| doi_str_mv | 10.1016/j.eururo.2008.11.028 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_734071499</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0302283808013614</els_id><sourcerecordid>734071499</sourcerecordid><originalsourceid>FETCH-LOGICAL-c276t-d202f3fcfc4112e892700120821a7db15026f18079677c1bae8a0067ffd7e7f33</originalsourceid><addsrcrecordid>eNpFkd9u0zAUxi0EYmXwBgj5jqtk59hpnHCBxKoBk4Z20SIuLdc5Lu6SuNhJpb4A77MX4ZlI10q7smx_3_nz_Rh7j5AjYHm1zWmMYwy5AKhyxBxE9YLNsFIyU_MSXrIZSBCZqGR1wd6ktAUAOa_la3aBNSgoBMzY35vGDyF60_JF6DrqBx76T3wV2oFiaHxPfBXJDE8_t90uhj0lvpwsZkN8eeh2Q-imh3GzoTT4PfHg-P2eorFPt-vWNA1F7nv-g_pTLWr4Lz_85v8es-s22AeK6S175Uyb6N35vGQ_v96sFt-zu_tvt4svd5kVqhyyRoBw0llnC0RBVS0UAAqoBBrVrHEOonRYgapLpSyuDVUGoFTONYqUk_KSfTzVnRb5M04T684nS21regpj0koWoLCo60lZnJQ2hpQiOb2LvjPxoBH0EYDe6hMAfQSgEfUEYLJ9ODcY1x01z6Zz4pPg80lA05p7T1Hb1vfemvaBDpS2YYz9lIBGnYQGvTwyPCKEClCWWMj_bkaapg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>734071499</pqid></control><display><type>article</type><title>Editorial Comment on: Tolterodine Treatment Improves Storage Symptoms Suggestive of Overactive Bladder in Men Treated With α-Blockers</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Speakman, Mark J</creator><creatorcontrib>Speakman, Mark J</creatorcontrib><identifier>ISSN: 0302-2838</identifier><identifier>EISSN: 1873-7560</identifier><identifier>DOI: 10.1016/j.eururo.2008.11.028</identifier><identifier>PMID: 19070420</identifier><language>eng</language><publisher>Switzerland</publisher><subject>Adrenergic alpha-Antagonists - therapeutic use ; Benzhydryl Compounds - therapeutic use ; Cresols - therapeutic use ; Drug Therapy, Combination ; Humans ; Male ; Muscarinic Antagonists - therapeutic use ; Phenylpropanolamine - therapeutic use ; Prostatism - complications ; Prostatism - drug therapy ; Tolterodine Tartrate ; Urinary Bladder, Overactive - diagnosis ; Urinary Bladder, Overactive - drug therapy ; Urinary Bladder, Overactive - etiology ; Urology</subject><ispartof>European urology, 2009-09, Vol.56 (3), p.542-543</ispartof><rights>European Association of Urology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c276t-d202f3fcfc4112e892700120821a7db15026f18079677c1bae8a0067ffd7e7f33</citedby><cites>FETCH-LOGICAL-c276t-d202f3fcfc4112e892700120821a7db15026f18079677c1bae8a0067ffd7e7f33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19070420$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Speakman, Mark J</creatorcontrib><title>Editorial Comment on: Tolterodine Treatment Improves Storage Symptoms Suggestive of Overactive Bladder in Men Treated With α-Blockers</title><title>European urology</title><addtitle>Eur Urol</addtitle><subject>Adrenergic alpha-Antagonists - therapeutic use</subject><subject>Benzhydryl Compounds - therapeutic use</subject><subject>Cresols - therapeutic use</subject><subject>Drug Therapy, Combination</subject><subject>Humans</subject><subject>Male</subject><subject>Muscarinic Antagonists - therapeutic use</subject><subject>Phenylpropanolamine - therapeutic use</subject><subject>Prostatism - complications</subject><subject>Prostatism - drug therapy</subject><subject>Tolterodine Tartrate</subject><subject>Urinary Bladder, Overactive - diagnosis</subject><subject>Urinary Bladder, Overactive - drug therapy</subject><subject>Urinary Bladder, Overactive - etiology</subject><subject>Urology</subject><issn>0302-2838</issn><issn>1873-7560</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkd9u0zAUxi0EYmXwBgj5jqtk59hpnHCBxKoBk4Z20SIuLdc5Lu6SuNhJpb4A77MX4ZlI10q7smx_3_nz_Rh7j5AjYHm1zWmMYwy5AKhyxBxE9YLNsFIyU_MSXrIZSBCZqGR1wd6ktAUAOa_la3aBNSgoBMzY35vGDyF60_JF6DrqBx76T3wV2oFiaHxPfBXJDE8_t90uhj0lvpwsZkN8eeh2Q-imh3GzoTT4PfHg-P2eorFPt-vWNA1F7nv-g_pTLWr4Lz_85v8es-s22AeK6S175Uyb6N35vGQ_v96sFt-zu_tvt4svd5kVqhyyRoBw0llnC0RBVS0UAAqoBBrVrHEOonRYgapLpSyuDVUGoFTONYqUk_KSfTzVnRb5M04T684nS21regpj0koWoLCo60lZnJQ2hpQiOb2LvjPxoBH0EYDe6hMAfQSgEfUEYLJ9ODcY1x01z6Zz4pPg80lA05p7T1Hb1vfemvaBDpS2YYz9lIBGnYQGvTwyPCKEClCWWMj_bkaapg</recordid><startdate>200909</startdate><enddate>200909</enddate><creator>Speakman, Mark J</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200909</creationdate><title>Editorial Comment on: Tolterodine Treatment Improves Storage Symptoms Suggestive of Overactive Bladder in Men Treated With α-Blockers</title><author>Speakman, Mark J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c276t-d202f3fcfc4112e892700120821a7db15026f18079677c1bae8a0067ffd7e7f33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adrenergic alpha-Antagonists - therapeutic use</topic><topic>Benzhydryl Compounds - therapeutic use</topic><topic>Cresols - therapeutic use</topic><topic>Drug Therapy, Combination</topic><topic>Humans</topic><topic>Male</topic><topic>Muscarinic Antagonists - therapeutic use</topic><topic>Phenylpropanolamine - therapeutic use</topic><topic>Prostatism - complications</topic><topic>Prostatism - drug therapy</topic><topic>Tolterodine Tartrate</topic><topic>Urinary Bladder, Overactive - diagnosis</topic><topic>Urinary Bladder, Overactive - drug therapy</topic><topic>Urinary Bladder, Overactive - etiology</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Speakman, Mark J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Speakman, Mark J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Editorial Comment on: Tolterodine Treatment Improves Storage Symptoms Suggestive of Overactive Bladder in Men Treated With α-Blockers</atitle><jtitle>European urology</jtitle><addtitle>Eur Urol</addtitle><date>2009-09</date><risdate>2009</risdate><volume>56</volume><issue>3</issue><spage>542</spage><epage>543</epage><pages>542-543</pages><issn>0302-2838</issn><eissn>1873-7560</eissn><cop>Switzerland</cop><pmid>19070420</pmid><doi>10.1016/j.eururo.2008.11.028</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0302-2838 |
| ispartof | European urology, 2009-09, Vol.56 (3), p.542-543 |
| issn | 0302-2838 1873-7560 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_734071499 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Adrenergic alpha-Antagonists - therapeutic use Benzhydryl Compounds - therapeutic use Cresols - therapeutic use Drug Therapy, Combination Humans Male Muscarinic Antagonists - therapeutic use Phenylpropanolamine - therapeutic use Prostatism - complications Prostatism - drug therapy Tolterodine Tartrate Urinary Bladder, Overactive - diagnosis Urinary Bladder, Overactive - drug therapy Urinary Bladder, Overactive - etiology Urology |
| title | Editorial Comment on: Tolterodine Treatment Improves Storage Symptoms Suggestive of Overactive Bladder in Men Treated With α-Blockers |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T04%3A59%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Editorial%20Comment%20on:%20Tolterodine%20Treatment%20Improves%20Storage%20Symptoms%20Suggestive%20of%20Overactive%20Bladder%20in%20Men%20Treated%20With%20%CE%B1-Blockers&rft.jtitle=European%20urology&rft.au=Speakman,%20Mark%20J&rft.date=2009-09&rft.volume=56&rft.issue=3&rft.spage=542&rft.epage=543&rft.pages=542-543&rft.issn=0302-2838&rft.eissn=1873-7560&rft_id=info:doi/10.1016/j.eururo.2008.11.028&rft_dat=%3Cproquest_cross%3E734071499%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=734071499&rft_id=info:pmid/19070420&rft_els_id=1_s2_0_S0302283808013614&rfr_iscdi=true |